275 related articles for article (PubMed ID: 11602691)
1. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
[TBL] [Abstract][Full Text] [Related]
2. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
3. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
Paliogianni F; Boumpas DT
Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP.
Tsuruta L; Lee HJ; Masuda ES; Koyano-Nakagawa N; Arai N; Arai K; Yokota T
J Immunol; 1995 May; 154(10):5255-64. PubMed ID: 7730629
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mitogen-activated protein kinase kinase kinase reversed cAMP inhibition of NF-kappaB in T cells.
Ho HY; Lee HH; Lai MZ
Eur J Immunol; 1997 Jan; 27(1):222-6. PubMed ID: 9022022
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
8. Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor.
Claveau D; Chen SL; O'Keefe S; Zaller DM; Styhler A; Liu S; Huang Z; Nicholson DW; Mancini JA
J Pharmacol Exp Ther; 2004 Aug; 310(2):752-60. PubMed ID: 15082748
[TBL] [Abstract][Full Text] [Related]
9. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
Kasyapa CS; Stentz CL; Davey MP; Carr DW
J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
[TBL] [Abstract][Full Text] [Related]
10. Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.
Edmead CE; Patel YI; Wilson A; Boulougouris G; Hall ND; Ward SG; Sansom DM
J Immunol; 1996 Oct; 157(8):3290-7. PubMed ID: 8871623
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings.
Feske S; Müller JM; Graf D; Kroczek RA; Dräger R; Niemeyer C; Baeuerle PA; Peter HH; Schlesier M
Eur J Immunol; 1996 Sep; 26(9):2119-26. PubMed ID: 8814256
[TBL] [Abstract][Full Text] [Related]
12. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
14. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
Yamamoto S; Sugahara S; Naito R; Ichikawa A; Ikeda K; Yamada T; Shimizu Y
Eur J Pharmacol; 2006 Jul; 541(1-2):106-14. PubMed ID: 16780833
[TBL] [Abstract][Full Text] [Related]
15. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
16. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
[TBL] [Abstract][Full Text] [Related]
17. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
18. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4.
Brown DM; Hutchison L; Donaldson K; MacKenzie SJ; Dick CA; Stone V
Toxicol Lett; 2007 Jan; 168(1):1-6. PubMed ID: 17129690
[TBL] [Abstract][Full Text] [Related]
19. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
Heijink IH; Kauffman HF; Postma DS; de Monchy JG; Vellenga E
Eur J Immunol; 2003 Aug; 33(8):2206-15. PubMed ID: 12884295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
